metypred 4mg tableta
orion corporation, espoo array - 937 methylprednisolon - tableta - 4mg - methylprednisolon
advantan 1mg/g krém
leo pharma a/s, ballerup array - 9339 methylprednisolon-aceponÁt - krém - 1mg/g - methylprednisolon-aceponÁt
advantan mastný krém 1mg/g krém
leo pharma a/s, ballerup array - 9339 methylprednisolon-aceponÁt - krém - 1mg/g - methylprednisolon-aceponÁt
advantan mléko 1mg/g kožní emulze
leo pharma a/s, ballerup array - 9339 methylprednisolon-aceponÁt - kožní emulze - 1mg/g - methylprednisolon-aceponÁt
depo-medrol 40mg/ml injekční suspenze
pfizer, spol. s r.o., praha array - 938 methylprednisolon-acetÁt - injekční suspenze - 40mg/ml - methylprednisolon
zytiga
janssen-cilag international n.v. - abirateron acetátu - prostatetické novotvary - endokrinní terapie - zytiga je indikována spolu s prednisonem či prednisolonem pro:léčbu metastatického kastraci rezistentní rakovinou prostaty u dospělých mužů, kteří jsou asymptomatičtí nebo mírně symptomatických po selhání androgen deprivační terapie u kterých chemoterapie není dosud klinicky indicatedthe léčbě metastatického kastraci rezistentní rakovinou prostaty u dospělých mužů, jejichž onemocnění se vyvíjí, nebo po docetaxelu na bázi chemoterapie.
abiraterone accord
accord healthcare s.l.u. - abirateron acetátu - prostatetické novotvary - endokrinní terapie - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone mylan
mylan ireland limited - abirateron acetátu - prostatetické novotvary - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abirateron acetátu - prostatetické novotvary - endokrinní terapie - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
abiraterone glenmark 500mg potahovaná tableta
glenmark pharmaceuticals s.r.o., praha array - 19572 abirateron-acetÁt - potahovaná tableta - 500mg - abirateron